PA
CL icon

Parallel Advisors’s Colgate-Palmolive CL Stock Holding History

Parallel Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.44M Buy
75,617
+54
+0.1% +$4.81K 0.12% 133
2025
Q4 		$5.97M Sell
75,563
-4,353
-5% -$341K 0.11% 140
2025
Q3 		$6.39M Sell
79,916
-6,477
-7% -$553K 0.12% 121
2025
Q2 		$7.85M Sell
86,393
-1,978
-2% -$181K 0.16% 100
2025
Q1 		$8.28M Sell
88,371
-1,167
-1% -$104K 0.19% 92
2024
Q4 		$8.14M Sell
89,538
-910
-1% -$86.8K 0.18% 93
2024
Q3 		$9.39M Sell
90,448
-376
-0.4% -$38.3K 0.22% 79
2024
Q2 		$8.81M Buy
90,824
+613
+0.7% +$56.5K 0.23% 81
2024
Q1 		$8.12M Buy
90,211
+5,436
+6% +$461K 0.22% 84
2023
Q4 		$6.76M Buy
84,775
+3,638
+4% +$274K 0.2% 90
2023
Q3 		$5.77M Buy
81,137
+578
+0.7% +$43.2K 0.19% 98
2023
Q2 		$6.21M Buy
80,559
+1,371
+2% +$106K 0.2% 96
2023
Q1 		$5.95M Buy
79,188
+70,790
+843% +$5.26M 0.2% 97
2022
Q4 		$662K Sell
8,398
-3,132
-27% -$235K 0.03% 341
2022
Q3 		$810K Sell
11,530
-668
-5% -$52.4K 0.04% 275
2022
Q2 		$978K Buy
12,198
+3,271
+37% +$256K 0.04% 250
2022
Q1 		$682K Sell
8,927
-1,096
-11% -$86.8K 0.03% 348
2021
Q4 		$855K Buy
10,023
+2,005
+25% +$157K 0.03% 315
2021
Q3 		$606K Sell
8,018
-3,817
-32% -$303K 0.02% 355
2021
Q2 		$963K Buy
11,835
+1,920
+19% +$157K 0.04% 262
2021
Q1 		$782K Buy
9,915
+620
+7% +$48.6K 0.04% 270
2020
Q4 		$795K Buy
9,295
+674
+8% +$55.7K 0.04% 244
2020
Q3 		$665K Sell
8,621
-1,067
-11% -$81.4K 0.04% 247
2020
Q2 		$709K Buy
9,688
+2,584
+36% +$184K 0.05% 235
2020
Q1 		$471K Buy
7,104
+498
+8% +$35.1K 0.04% 257
2019
Q4 		$455K Buy
6,606
+43
+0.7% +$2.93K 0.03% 306
2019
Q3 		$482K Buy
6,563
+217
+3% +$15.7K 0.04% 273
2019
Q2 		$454K Sell
6,346
-410
-6% -$29.1K 0.04% 255
2019
Q1 		$463K Buy
6,756
+545
+9% +$35.2K 0.05% 233
2018
Q4 		$369K Sell
6,211
-224
-3% -$14K 0.05% 245
2018
Q3 		$431K Sell
6,435
-36
-0.6% -$2.4K 0.05% 229
2018
Q2 		$419K Buy
6,471
+121
+2% +$7.92K 0.06% 209
2018
Q1 		$455K Buy
6,350
+55
+0.9% +$3.96K 0.07% 187
2017
Q4 		$475K Sell
6,295
-3
-0% -$219 0.08% 178
2017
Q3 		$464K Buy
6,298
+153
+2% +$11K 0.08% 175
2017
Q2 		$444K Buy
6,145
+105
+2% +$7.8K 0.08% 175
2017
Q1 		$429K Buy
6,040
+406
+7% +$28.4K 0.09% 170
2016
Q4 		$369K Buy
+5,634
New +$386K 0.09% 166

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Parallel Advisors's CL Position: Q1 2026 in Review

Parallel Advisors increased its Colgate-Palmolive (CL) stake by 0.07% in Q1 2026, buying an estimated $4.81K and bringing the position to 75,617 shares worth $6.44M. The position accounts for 0.12% of the portfolio, ranked #133.

Parallel Advisors first reported a position in CL in Q4 2016 and has held it in 38 quarters since. The position peaked at $9.39M in Q3 2024. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Parallel Advisors held 75,617 shares of Colgate-Palmolive worth $6.44M as of Q1 2026.
  • Parallel Advisors bought 54 Colgate-Palmolive shares in Q1 2026, an estimated $4.81K.
  • Colgate-Palmolive made up 0.12% of Parallel Advisors's portfolio in Q1 2026, its #133 holding.
  • Parallel Advisors first reported a position in Colgate-Palmolive in Q4 2016 and has held it in 38 quarters since.
  • Parallel Advisors's Colgate-Palmolive position peaked at $9.39M in Q3 2024.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.